Showing results (91-100 of 129) with videos related to
Sort By:
Pageof 13
The Journal of Pediatrics|July 2, 2002
Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 gRolf F Maier, Michael Obladen, Ingo Müller-Hansen, et al.Stem Cells and Development|January 15, 2021
Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host DiseaseMichaela Döring, Karin Melanie Cabanillas Stanchi, Katrin Lenglinger, et al.Journal of Hazardous Materials|November 14, 2021
Risk management for arsenic in agricultural soil-water systems: lessons learned from case studies in EuropeKirsti Loukola-Ruskeeniemi, Ingo Müller, Susan Reichel, et al.International Journal of Oncology|March 16, 2022
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patientsMaria-Luisa Schubert, Carolina Berger, Alexander Kunz, et al.British Journal of Haematology|May 28, 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study GroupHerbert Pichler, Petr Sedlacek, Roland Meisel, et al.Journal of Molecular and Cellular Cardiology|March 31, 2009
Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitroHarald F Langer, Konstantinos Stellos, Caroline Steingen, et al.The Science of the Total Environment|August 10, 2014
Selecting chemical and ecotoxicological test batteries for risk assessment of trace element-contaminated soils (phyto)managed by gentle remediation options (GRO)Jurate Kumpiene, Valérie Bert, Ioannis Dimitriou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2019
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T CellsSareetha Kailayangiri, Bianca Altvater, Stefanie Lesch, et al.British Journal of Haematology|December 6, 2017
CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantationChiara Mainardi, Martin Ebinger, Sigrid Enkel, et al.Pageof 13